Skip to content

Role of Arjuna Twak Churna Lepa on Vyanga (Melasma) with Reference to Doshaj Prakriti

To Evaluate the Efficacy of ARJUNA Twak Churna Lepa in the Management of Vyanga (Melasma) in Relation to Doshaj Prakriti - Arjun Vyanga

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102932
Enrollment
60
Registered
2026-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L08- Infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Pt khushilal Sharma Government Ayurveda College and Institute Bhopal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Only female patients aged between 20 to 40 years irrespective of caste, religion, occupation etc Patients fulfilling the criteria of Vyanga presenting with clinical symptoms of Vyanga Patients willing to give written consent for study and visual and audio recording

Exclusion criteria

Exclusion criteria: Patient having other skin diseases like Psoriasis, Atopic dermatitis, SLE (Systemic lupus erythematosus) leprosy etc Pregnant and Lactating Women. Patients taking steroids or hormonal therapy Patients with known allergies to herbal formulations or Arjuna

Design outcomes

Primary

MeasureTime frame
At the end of the study we would be able to evaluate the efficacy of ARJUNA Twak Churna Lepa in the management of Vyanga (Melasma) in relation to Doshaj PrakritiTimepoint: 4 Weeks

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Babita Sharma

Pt khushilal Sharma Government Ayurveda College and Institute Bhopal

drbabitasharma5@gmail.com9893352450

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026